IP Library Granted Patent US 10,336,992
Granted Patent B2
US 10,336,992 · App. 14/128,468 · Granted Jul 2, 2019

Methods for purification of arylsulfatase A

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,336,992
App. No.
14/128,468
Granted
Jul 2, 2019
Kind
B2
Abstract

Methods of producing arylsulfatase A are described herein. The methods can include one or more steps of chromatography. Exemplary chromatographic steps include ion exchange chromatography, mixed mode chromatography, and hydrophobic interaction chromatography. Compositions containing and methods using arylsulfatase A produced by the methods described herein are also disclosed.

Claims (13)

1. A method of purifying recombinant arylsulfatase A (ASA) protein, comprising

providing a sample of recombinant ASA protein;

subjecting the sample to a first chromatography step which is anion exchange chromatography,

subjecting the sample from the anion exchange chromatography to a second chromatography step which is mixed-mode chromatography,

subjecting the sample from the mixed-mode chromatography to a third chromatography step which is hydrophobic interaction chromatography, and

subjecting the sample from the hydrophobic interaction chromatography to a fourth chromatography step which is cation exchange chromatography,

wherein fractions from each chromatography step containing recombinant ASA protein are determined by detecting the presence of recombinant ASA protein or enzymatic activity, and

wherein the purified recombinant ASA protein has a specific activity of at least 75 U/mg,

wherein 1 Unit of enzyme activity is defined as the hydrolysis of 1 μmol p-Nitrocatechol Sulphate (pNCS) per minute at 37° C., pH 5.0.

2. The method of claim 1 , wherein the sample of recombinant ASA protein is obtained from cultured cell extract or cell culture supernatant.

3. The method of claim 1 , wherein the cation exchange chromatography is sulfopropyl (SP) cation exchange chromatography.

4. The method of claim 1 , wherein the mixed-mode chromatography is hydroxyapatite (HA) chromatography.

5. The method of claim 1 , wherein the hydrophobic interaction chromatography is phenyl chromatography.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 30, 2021
From: SHIRE HUMAN GENETIC THERAPIES, INC.
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 055766/0572 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 18, 2014
From: YANG, YING; WANG, YONG
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 032459/0307 →